Update: 11.06.2024
Last week: 22 week 2024 (27.05.2024 - 02.06.2024)
Last full month: May 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 6 673 | -10.1% | 10.9% | -0.5 | 14 453 051 | -10.4% | 9.0% | -0.5 | -5.6% |
| MoM | 30 129 | -17.3% | 11.2% | -0.3 | 65 855 813 | -18.2% | 9.3% | -0.4 | -15.3% |
| YTD | 158 795 | 21.0% | 11.1% | 2.4 | 353 431 804 | 48.2% | 9.4% | 2.1 | -5.3% |
| MAT | 368 368 | 31.1% | 10.1% | 1.9 | 771 842 647 | 50.3% | 8.6% | 1.5 | 6.6% |
| BRAINMAX | |||||||||
| WoW | 1 066 | 0.9% | 100.0% | 0 | 4 003 771 | 2.4% | 100.0% | 0 | 0.9% |
| MoM | 4 260 | -14.9% | 100.0% | 0 | 15 726 416 | -12.6% | 100.0% | 0 | -11.4% |
| YTD | 22 552 | 41.8% | 100.0% | 0 | 81 713 266 | 52.5% | 100.0% | 0 | 41.8% |
| MAT | 53 301 | 104.3% | 100.0% | 0 | 189 143 770 | 119.1% | 100.0% | 0 | 104.3% |
| GOLDLINE PLUS | |||||||||
| WoW | 17 540 | -4.2% | 45.2% | 1.1 | 53 727 842 | -5.6% | 36.4% | 1 | -6.5% |
| MoM | 77 761 | -2.4% | 44.6% | -1.1 | 241 414 256 | -3.8% | 36.0% | -1.3 | 0.1% |
| YTD | 377 950 | -1.9% | 44.5% | 1.2 | 1 197 124 955 | 2.4% | 36.3% | -3 | -4.4% |
| MAT | 861 846 | 11.9% | 45.5% | 1.4 | 2 719 981 870 | 19.7% | 38.3% | -0.9 | 8.5% |
| MIGRENIUM | |||||||||
| WoW | 10 414 | 0.5% | 0.5% | 0 | 3 415 465 | 0.7% | 0.7% | 0 | -1.8% |
| MoM | 47 431 | -22.4% | 0.5% | -0.1 | 15 520 654 | -19.7% | 0.7% | -0.1 | -5.4% |
| YTD | 267 250 | 0.7% | 0.6% | -0.1 | 80 086 738 | 67.4% | 0.7% | 0.2 | 15.1% |
| MAT | 643 544 | 5.6% | 0.5% | -0.1 | 154 920 731 | 40.0% | 0.6% | 0 | 17.1% |
| MODELAX-N | |||||||||
| WoW | 25 883 | 1.7% | 21.4% | 1 | 11 656 105 | 1.8% | 14.3% | 0.7 | -3.1% |
| MoM | 114 358 | -16.8% | 21.2% | -3.6 | 51 176 839 | -13.5% | 14.1% | -2.2 | -2.5% |
| YTD | 673 316 | 45.4% | 23.3% | 4.9 | 282 885 265 | 94.7% | 14.8% | 4.4 | 14.8% |
| MAT | 1 378 267 | 84.6% | 20.7% | 6.9 | 520 363 621 | 115.8% | 12.3% | 4.4 | 23.1% |
| REDUXIN | |||||||||
| WoW | 12 782 | -9.0% | 32.9% | -0.9 | 68 292 670 | -9.9% | 46.2% | -0.8 | -6.5% |
| MoM | 58 125 | 2.5% | 33.3% | 0.8 | 312 000 841 | 1.8% | 46.6% | 1 | 0.1% |
| YTD | 281 416 | -7.5% | 33.2% | -1.1 | 1 525 263 530 | 20.7% | 46.2% | 3.8 | -4.4% |
| MAT | 615 182 | 1.3% | 32.5% | -2.3 | 3 134 896 599 | 24.9% | 44.1% | 0.9 | 8.5% |
| REDUXIN FORTE | |||||||||
| WoW | 3 343 | -5.1% | 8.6% | 0.1 | 14 331 143 | -7.9% | 9.7% | 0 | -6.5% |
| MoM | 14 818 | -2.2% | 8.5% | -0.2 | 64 281 430 | -0.5% | 9.6% | 0 | 0.1% |
| YTD | 73 612 | 4.6% | 8.7% | 0.7 | 320 787 954 | 21.9% | 9.7% | 0.9 | -4.4% |
| MAT | 169 235 | 24.9% | 8.9% | 1.2 | 711 249 622 | 38.6% | 10.0% | 1.2 | 8.5% |
| SALVISAR | |||||||||
| WoW | 10 630 | -9.0% | 1.5% | 0 | 4 478 139 | -9.3% | 1.4% | -0.1 | -6.7% |
| MoM | 52 155 | -12.0% | 1.6% | -0.1 | 21 993 076 | -9.9% | 1.5% | -0.1 | -5.5% |
| YTD | 235 413 | 1.8% | 1.4% | 0 | 93 157 179 | 24.9% | 1.3% | 0 | 3.3% |
| MAT | 502 499 | -13.6% | 1.2% | -0.3 | 182 344 202 | -7.4% | 1.1% | -0.3 | 7.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 158 795 | 21.0% | 11.1% | 2.4 | 353 431 804 | 48.2% | 9.4% | 2.1 | -5.3% |
| BRAINMAX | 22 552 | 41.8% | 100.0% | 0 | 81 713 266 | 52.5% | 100.0% | 0 | 41.8% |
| GOLDLINE PLUS | 377 950 | -1.9% | 44.5% | 1.2 | 1 197 124 955 | 2.4% | 36.3% | -3 | -4.4% |
| MIGRENIUM | 267 250 | 0.7% | 0.6% | -0.1 | 80 086 738 | 67.4% | 0.7% | 0.2 | 15.1% |
| MODELAX-N | 673 316 | 45.4% | 23.3% | 4.9 | 282 885 265 | 94.7% | 14.8% | 4.4 | 14.8% |
| REDUXIN CAPS | 281 416 | -7.5% | 33.2% | -1.1 | 1 525 263 530 | 20.7% | 46.2% | 3.8 | -4.4% |
| REDUXIN FORTE | 73 612 | 4.6% | 8.7% | 0.7 | 320 787 954 | 21.9% | 9.7% | 0.9 | -4.4% |
| SALVISAR | 235 413 | 1.8% | 1.4% | 0 | 93 157 179 | 24.9% | 1.3% | 0 | 3.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 368 368 | 31.1% | 10.1% | 1.9 | 771 842 647 | 50.3% | 8.6% | 1.5 | 6.6% |
| BRAINMAX | 53 301 | 104.3% | 100.0% | 0 | 189 143 770 | 119.1% | 100.0% | 0 | 104.3% |
| GOLDLINE PLUS | 861 846 | 11.9% | 45.5% | 1.4 | 2 719 981 870 | 19.7% | 38.3% | -0.9 | 8.5% |
| MIGRENIUM | 643 544 | 5.6% | 0.5% | -0.1 | 154 920 731 | 40.0% | 0.6% | 0 | 17.1% |
| MODELAX-N | 1 378 267 | 84.6% | 20.7% | 6.9 | 520 363 621 | 115.8% | 12.3% | 4.4 | 23.1% |
| REDUXIN CAPS | 615 182 | 1.3% | 32.5% | -2.3 | 3 134 896 599 | 24.9% | 44.1% | 0.9 | 8.5% |
| REDUXIN FORTE | 169 235 | 24.9% | 8.9% | 1.2 | 711 249 622 | 38.6% | 10.0% | 1.2 | 8.5% |
| SALVISAR | 502 499 | -13.6% | 1.2% | -0.3 | 182 344 202 | -7.4% | 1.1% | -0.3 | 7.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 6 673 | -10.1% | 10.9% | -0.5 | 14 453 051 | -10.4% | 9.0% | -0.5 | -5.6% |
| BRAINMAX | 1 066 | 0.9% | 100.0% | 0 | 4 003 771 | 2.4% | 100.0% | 0 | 0.9% |
| GOLDLINE PLUS | 17 540 | -4.2% | 45.2% | 1.1 | 53 727 842 | -5.6% | 36.4% | 1 | -6.5% |
| MIGRENIUM | 10 414 | 0.5% | 0.5% | 0 | 3 415 465 | 0.7% | 0.7% | 0 | -1.8% |
| MODELAX-N | 25 883 | 1.7% | 21.4% | 1 | 11 656 105 | 1.8% | 14.3% | 0.7 | -3.1% |
| REDUXIN CAPS | 12 782 | -9.0% | 32.9% | -0.9 | 68 292 670 | -9.9% | 46.2% | -0.8 | -6.5% |
| REDUXIN FORTE | 3 343 | -5.1% | 8.6% | 0.1 | 14 331 143 | -7.9% | 9.7% | 0 | -6.5% |
| SALVISAR | 10 630 | -9.0% | 1.5% | 0 | 4 478 139 | -9.3% | 1.4% | -0.1 | -6.7% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 30 129 | -17.3% | 11.2% | -0.3 | 65 855 813 | -18.2% | 9.3% | -0.4 | -15.3% |
| BRAINMAX | 4 260 | -14.9% | 100.0% | 0 | 15 726 416 | -12.6% | 100.0% | 0 | -11.4% |
| GOLDLINE PLUS | 77 761 | -2.4% | 44.6% | -1.1 | 241 414 256 | -3.8% | 36.0% | -1.3 | 0.1% |
| MIGRENIUM | 47 431 | -22.4% | 0.5% | -0.1 | 15 520 654 | -19.7% | 0.7% | -0.1 | -5.4% |
| MODELAX-N | 114 358 | -16.8% | 21.2% | -3.6 | 51 176 839 | -13.5% | 14.1% | -2.2 | -2.5% |
| REDUXIN CAPS | 58 125 | 2.5% | 33.3% | 0.8 | 312 000 841 | 1.8% | 46.6% | 1 | 0.1% |
| REDUXIN FORTE | 14 818 | -2.2% | 8.5% | -0.2 | 64 281 430 | -0.5% | 9.6% | 0 | 0.1% |
| SALVISAR | 52 155 | -12.0% | 1.6% | -0.1 | 21 993 076 | -9.9% | 1.5% | -0.1 | -5.5% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs